Global Immunology Policy & Public Affairs Lead

UCB

Anderlecht

Hybrid

EUR 120,000 - 160,000

Full time

2 days ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

UCB is seeking a senior Immunology Policy & Public Affairs Strategy Lead to define and drive global policy strategies. You will provide line management to senior colleagues and coordinate with Global Policy, Public Affairs and Payer Insights teams to anticipate policy changes that affect asset value, patient access and commercial strategy.

The role sits in Brussels, Belgium, with a hybrid work model and collaboration across global and regional teams to shape policy environments and enable

Qualifications

  • Significant senior-level experience in policy, public affairs and/or market access within regulated environments.
  • Strong strategic and analytical capability to translate external developments into implications for assets and patient access.
  • Proven ability to lead, influence stakeholders and manage senior colleagues.

Responsibilities

  • Define and lead the global Immunology Policy & Public Affairs strategy, priorities and direction.
  • Lead line management of senior colleagues to drive high performance.
  • Translate external policy analysis into implications for assets, commercial strategy and patient access.
  • Identify transversal opportunities across assets, disease areas, geographies and functions.
  • Provide policy insights to asset teams to inform decisions across the lifecycle.
  • Build partnerships across global, regional and functional teams to align priorities.
  • Engage external stakeholders to advance patient-focused policy solutions.
  • Anticipate external changes and adapt strategy accordingly.

Skills

Policy strategy
Public affairs
Market access
Stakeholder management
Strategic thinking
Leadership

Education

Master's degree in life sciences
PhD preferred

Job description

UCB is seeking a senior Immunology Policy & Public Affairs Strategy Lead to define and drive global policy strategies. You will provide line management to senior colleagues and coordinate with Global Policy, Public Affairs and Payer Insights teams to anticipate policy changes that affect asset value, patient access and commercial strategy.

The role sits in Brussels, Belgium, with a hybrid work model and collaboration across global and regional teams to shape policy environments and enable

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global Access & Pricing Strategy Lead - Immunology
Global Access & Pricing Strategy Lead - Immunology

UCB S.A. • Anderlecht

Hybrid
EUR 110,000 - 150,000
Immunology Policy & Public Affairs Strategy Lead (UK)
Immunology Policy & Public Affairs Strategy Lead (UK)

UCB • Anderlecht

Hybrid
EUR 120,000 - 160,000
Global Medical Evidence Strategy Lead
Global Medical Evidence Strategy Lead

UCB • Brussel

Hybrid
EUR 120,000 - 170,000
Hybrid work model
Senior Leader, Neuroinflammation & Neuroimmunology Research
Senior Leader, Neuroinflammation & Neuroimmunology Research

UCB • Eigenbrakel

On-site
EUR 90,000 - 120,000
Access & Pricing Strategy Team Lead - Neurology (Belgium) 1
Access & Pricing Strategy Team Lead - Neurology (Belgium) 1

UCB • Anderlecht

Hybrid
EUR 110,000 - 150,000
Global RWE Strategy Leader, Immunology
Global RWE Strategy Leader, Immunology

UCB • Brussel

Hybrid
EUR 110,000 - 140,000
Hybrid work model
Global exposure
Global Payer Asset Head (Belgium)
Global Payer Asset Head (Belgium)

UCB • Anderlecht

Hybrid
EUR 180,000 - 240,000
Group Leader Neuroinflammation
Group Leader Neuroinflammation

UCB • Eigenbrakel

On-site
EUR 90,000 - 120,000
Strategic Global Outcomes Research Lead
Strategic Global Outcomes Research Lead

UCB • Anderlecht

Hybrid
EUR 85,000 - 125,000
Hybrid work model
Global exposure
Equal opportunity employer
Global Access & Pricing Strategy Lead - Neurology
Global Access & Pricing Strategy Lead - Neurology

UCB • Brussel

Hybrid
EUR 120,000 - 180,000